#AIPM2020
+
Pharmaceutical Medicine
May 18, 2020, Columbia University, NYC
Artificial Intelligence
Keynote Speakers
Mihaela van der Schaar PhD
John Humphrey Plummer Professor
University of Cambridge
TBD
Professor van der Schaar is Professor of Machine Learning, Artificial Intelligence and Medicine at the University of Cambridge and a Turing Fellow at The Alan Turing Institute in London, where she leads the effort on data science and machine learning for personalised medicine. She is an IEEE Fellow (2009). She has received the Oon Prize on Preventative Medicine from the University of Cambridge (2018).
Speakers
TBD
US FDA
Jesse Berlin, J&J
Lawrence Carin, Duke
Noémie Elhadad, Columbia
Faisal Khan, AstraZeneca
Wang Li, Abbvie
Kannan Natarajan, Pfizer
Adler Perotte, Columbia
Simon Tavaré, Columbia
Where will the AI revolution take pharmaceutical science?
Sponsors
Draft Program
Program Co-Chairs
Demissie Alemayehu, Pfizer & David Madigan, Columbia
7:30 AM – 8:25 AM
Registration and Breakfast
8:25 AM – 8:30 AM
Welcome Address
David Madigan, Ph.D., Columbia University
8:30 Am – 9:00 AM
Opening Plenary Session (Chair D. Madigan)
Kannan Natarajan, Ph.D., Pfizer Inc.
9:00 AM – 10:00 Am
Keynote Address I (Chair K. Natarajan)
Amy P. Abernethy, MD, Ph.D
US Food and Drug Administration (FDA)
10:00 AM – 10:30 AM
Break
10:30 AM - 11:00 AM
Plenary Session I (Chair, D. Alemayehu, Pfizer Inc)
“ML and AI in Clinical Development and Statistical Innovation in AbbVie.”
Wang Li, Ph.D., AbbVie
Lawrence Carin, Ph.D. Duke University
11:00 – 11:30
Break
11:30 – 12:00
12:00 – 12:30
Plenary Session II (Chair TBD)
“Artificial Intelligence in Pharmaceutical R&D at AstraZeneca.” Faisal Khan, AstraZeneca
Noémie Elhadad, Ph.D., Columbia University
12:30 -1:00
Lunch
1:00 – 2:00
Keynote Address II (Chair D. Madigan)
Mihaela van der Schaar
University of Cambridge and UCLA
2:00 – 2:30
Break
2:30 – 3:00
Plenary Session III (Chair TBD)
Adler Perotte, Columbia University
Jesse A. Berlin, Johnson & Johnson
3:00 – 3:15
Break
3:15 – 4:50
Panel Discussion: “Ethical Issues with AI in Clinical Drug Development”
(Moderator, Jeannette M. Wing, Ph.D., Columbia University)
-
FDA
-
TBD
-
TBD
4:50 – 5:00
Closing Remarks and wrap-up
Demissie Alemayehu, Ph.D., Pfizer Inc